TAYLOR SKINNER: Open Payments
NPI 1790412195 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,002 in 93 payments from 17 companies in 2025. Trend: 2023 $870 · 2024 $1,192 · 2025 $2,002
Food & beverage: $2,002
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $330 |
| Corium, LLC | 10 | $245 |
| Alkermes, Inc. | 10 | $238 |
| Axsome Therapeutics, Inc. | 9 | $173 |
| ABBVIE INC. | 10 | $172 |
| Vanda Pharmaceuticals Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $117 |
| Lundbeck LLC | 4 | $100 |
| Almatica Pharma LLC | 5 | $86 |
| Supernus Pharmaceuticals, Inc. | 3 | $85 |
Products named: INGREZZA, Azstarys, VRAYLAR, REXULTI, LYBALVI, FANAPT, Auvelity, CAPLYTA.
Industry payments across TN — which companies pay providers there.
